Recently an article got everyone's knickers in a twist about protein and CVD. Here's an easy to read summary of the paper with my pictorial essay medicalnewstoday.com/articles/eatin…
Note: this is a conclusion from mice only... it's translation to humans... 🧐
High protein diets may contribute (!!) but we should revise dietary guidelines (???) In our 2020 paper also in mice 🐭 🤨
We created diets in mice that mimicked what people are - at the highest end of intake...
Part I - 14 people! Part II - 9 people. Leucine - no reference or data 'cept for a 2020 paper in? You guessed it 🐁 😉
Activates a pathway in immune cells that's ASSociated with atherosclerosis... 🤔
Now we 'pin down' the reason - now it's causal (??) Leu is the 'bad actor' 🫤 (in mice anyway and 22% is the magic threshold)
2020 study in 🐁🐭
Another dude thinks this is not a big deal (I'd agree)
Takeaway... 23 people and acute immune cell signalling
Mice and 22% protein that 'mimics' the higher end of what humans ingest
It's only Leu...
Time to have a hard think about what the science is and the message being pushed. The data are mildly interesting and give some food for thought. I stop (well) short of seeing this as a smoking (protein-filled) fun and the reason to change dietary guidance OR to issue a per meal or dietary threshold advice to people.
I note the absence of a disease incidence, or risk or any causative data in humans...
Carry on folks: exercise, fuel to meet your needs, enjoy time with friends, lower your stress, have purpose in life and you will live well
Also, don't drink Boost with more protein on top... and stop feeding your mouse >22% protein! 😉
Just appreciate the limitations of the data and the model and the design and the ex-vivo outcomes and the murine model before we blow the horn for protein 'causes' CVD (or even increases risk). Also #Science
In short, mechanisms of hypertrophy are mostly internally driven intrinsic to the muscle itself Thanks @DrMikeRoberts
Short-term acute rises and menstrual cycle phase-based changes in hormones are not consequential to RT-induced hypertrophy.journals.physiology.org/doi/full/10.11…
Cortisol, often known as the “stress hormone,” has traditionally been associated with muscle breakdown and fat gain, particularly in stressful situations. But is cortisol 'bad' impairing fat mass loss and lean mass gains? A 🧵...
Research suggests that this relationship may not be as clear-cut, particularly in the context of exercise and controlled conditions. Studies have shown that cortisol does not significantly impede muscle mass gains or contribute to fat mass accumulation under certain conditions.
A study published in the European Journal of Applied Physiology observed that although cortisol levels rise following intense resistance training, these increases do not seem to inhibit muscle growth or strength gains.
Some believe muscle loss isn't important in drug-induced weight loss. We @DrCarlaPrado beg to differ.
No trial to date has assessed long-term changes in mobility or MSK health once people stop taking the drug (and regain fat)
Older patients with my comorbidities could be especially vulnerable.
Sarcopenic obesity is the confluence of two syndromes and conditions that could exacerbate many disorders. So, attention needs to be paid to minimizing muscle loss.
Association between dietary protein intake and risk of chronic kidney disease: a systematic review and meta-analysis frontiersin.org/journals/nutri…
The data showed a lower CKD risk significantly associated higher-level dietary total, plant or animal protein (especially for fish and seafood) intake.
More...
These data further indicate that, at least in the short term, higher protein intake within the range of recommended intakes for protein is consistent with normal kidney function in healthy individuals.sciencedirect.com/science/articl…
This was the original stated purpose "there are several innovative features of the proposed experiments that are expected to significantly advance the field and improve muscle regrowth and mobility, with the overall goal of reducing risk of disability among older adults.
The proposed work is expected to have a powerful impact, as we will be the first to determine whether metformin, in combination with resistance exercise designed to elicit muscle hypertrophy, will augment progressive resistance training-induced muscle gains
Pairwise meta-analyses compare one condition with another to determine which variable is best/better for an outcome. But what if you have multiple variables to manipulate? Like resistance exercise!
If resistance exercise (RE) is a drug and hypertrophy or strength is the outcome, then what if it’s not just the dose, but the frequency of how often you take the dose, how long you take the dose for, what if you take a big dose, a small dose, or you ramp up your dose